MapLight Therapeutics, Inc. (MPLT)
Nasdaq: MPLT · CIK 0001770069 · United States
Every official MapLight Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open MPLT filings
MapLight Therapeutics, Inc. documents
- MapLight Therapeutics, Inc. 10-K 2026MPLT 10-K 2026: annual report for fiscal 2026
- MapLight Therapeutics, Inc. 10-K 2025MPLT 10-K 2025: annual report for fiscal 2025
- MapLight Therapeutics, Inc. 10-K 2024MPLT 10-K 2024: annual report for fiscal 2024
- MapLight Therapeutics, Inc. 10-K 2023MPLT 10-K 2023: annual report for fiscal 2023
- MapLight Therapeutics, Inc. 10-K 2022MPLT 10-K 2022: annual report for fiscal 2022
- MapLight Therapeutics, Inc. 10-Q 2026MPLT 10-Q 2026: quarterly report for fiscal 2026
- MapLight Therapeutics, Inc. 10-Q 2025MPLT 10-Q 2025: quarterly report for fiscal 2025
- MapLight Therapeutics, Inc. 10-Q 2024MPLT 10-Q 2024: quarterly report for fiscal 2024
- MapLight Therapeutics, Inc. 10-Q 2023MPLT 10-Q 2023: quarterly report for fiscal 2023
- MapLight Therapeutics, Inc. 10-Q 2022MPLT 10-Q 2022: quarterly report for fiscal 2022
- MapLight Therapeutics, Inc. 8-K 2026MPLT 8-K 2026: current report for fiscal 2026
- MapLight Therapeutics, Inc. 8-K 2025MPLT 8-K 2025: current report for fiscal 2025
- MapLight Therapeutics, Inc. 8-K 2024MPLT 8-K 2024: current report for fiscal 2024
- MapLight Therapeutics, Inc. 8-K 2023MPLT 8-K 2023: current report for fiscal 2023
- MapLight Therapeutics, Inc. 8-K 2022MPLT 8-K 2022: current report for fiscal 2022
- MapLight Therapeutics, Inc. DEF 14A 2026MPLT DEF 14A 2026: proxy statement for fiscal 2026
- MapLight Therapeutics, Inc. DEF 14A 2025MPLT DEF 14A 2025: proxy statement for fiscal 2025
- MapLight Therapeutics, Inc. DEF 14A 2024MPLT DEF 14A 2024: proxy statement for fiscal 2024
- MapLight Therapeutics, Inc. DEF 14A 2023MPLT DEF 14A 2023: proxy statement for fiscal 2023
- MapLight Therapeutics, Inc. DEF 14A 2022MPLT DEF 14A 2022: proxy statement for fiscal 2022
- MapLight Therapeutics, Inc. Form 4 2026MPLT Form 4 2026: insider trading filing for fiscal 2026
- MapLight Therapeutics, Inc. Form 4 2025MPLT Form 4 2025: insider trading filing for fiscal 2025
- MapLight Therapeutics, Inc. Form 4 2024MPLT Form 4 2024: insider trading filing for fiscal 2024
- MapLight Therapeutics, Inc. Form 4 2023MPLT Form 4 2023: insider trading filing for fiscal 2023
- MapLight Therapeutics, Inc. Form 4 2022MPLT Form 4 2022: insider trading filing for fiscal 2022
- MapLight Therapeutics, Inc. S-1 2026MPLT S-1 2026: registration statement for fiscal 2026
- MapLight Therapeutics, Inc. S-1 2025MPLT S-1 2025: registration statement for fiscal 2025
- MapLight Therapeutics, Inc. S-1 2024MPLT S-1 2024: registration statement for fiscal 2024
- MapLight Therapeutics, Inc. S-1 2023MPLT S-1 2023: registration statement for fiscal 2023
- MapLight Therapeutics, Inc. S-1 2022MPLT S-1 2022: registration statement for fiscal 2022
- MapLight Therapeutics, Inc. 13F 2026MPLT 13F 2026: institutional holdings for fiscal 2026
- MapLight Therapeutics, Inc. 13F 2025MPLT 13F 2025: institutional holdings for fiscal 2025
- MapLight Therapeutics, Inc. 13F 2024MPLT 13F 2024: institutional holdings for fiscal 2024
- MapLight Therapeutics, Inc. 13F 2023MPLT 13F 2023: institutional holdings for fiscal 2023
- MapLight Therapeutics, Inc. 13F 2022MPLT 13F 2022: institutional holdings for fiscal 2022
More companies